Meet our panel of medical specialists

Research Review Australia works with over 70 local medical specialists to select and advise on the most important research from around the world. They advise on what really matters, what impact it has on local healthcare and what we need to do in our daily practice to accomodate new skills and knowledge. Select a category below to see more about each of our expert advisors.

Professor Peter Hersey

Professor Peter Hersey

Peter Hersey is an honorary Professor of Immuno Oncology in the University of Sydney and a faculty member of the Melanoma Institute Australia. He has conducted a number of phase I to III trials of immunotherapy in melanoma, including use of modified peptide antigens and dendritic cell vaccines. He has taken a leading role in studies investigating properties of melanoma cells that make them resistant to treatment and new treatment approaches to overcome these properties. He is generally recognized as a pioneer of immunotherapy for melanoma in Australia, and has participated in most of the key clinical trials on immunotherapy with immune checkpoint inhibitors. He continues translational research on melanoma in the Centenary Institute as joint holder of a NHMRC program grant on melanoma... read more »

Professor Michael Henderson

Professor Michael Henderson

Michael A Henderson is professor of surgery in the University of Melbourne and head of the multidisciplinary Melanoma and Skin Service at the Peter MacCallum Cancer Centre in Melbourne. He is a graduate of the University of Melbourne and after obtaining a Fellowship of the Royal Australasian College of Surgeons spent 2 1/2 years undertaking a fellowship in surgical oncology at the University of Texas MD Anderson Cancer Centre. His clinical practice is confined to surgical oncology. His major clinical interests are in the management of patients with melanoma and maintains an active clinical and translational research interest in melanoma. He led a major international multicentre study of adjuvant radiotherapy after link for melanoma and is currently the principal investigator of a multicentre international trial of margins of excision of intermediate and thick melanoma (MELMART)... read more »